How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study

Background There are several studies that have discussed the efficacy of telemedicine with amyotrophic lateral sclerosis (ALS) patients; however, this approach is still preliminary in Egypt and in North Africa.

The objective of the current study is to discuss current experience with telemedicine in monitoring patients in the specialized ALS clinic in Egypt.

Efficacy of Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) in monitoring disease progression remotely will be discussed.

Results This is a prospective study.

Forty-three ALS patients were included in this study in the period between July 1, 2020, and February 6, 2021.

Fifty-three telemedicine encounters and 13 post-telemedicine office visits were available.

None of the participating patients had COVID-19 infection.

Eight patients showed decline in ALSFRS score.

ALSFRS-R score reported during telemedicine encounters was confirmed during office visits.

Three bulbar onset ALS patients had gastrostomy, and 2 bulbar onset ALS patients had Botox injection for drooling.

All eight patients with declining ALSFRS-R were maintained on non-invasive ventilation (NIV) based on their symptoms.

Conclusion This is the first study discussing telemedicine in the field of ALS in Egypt and North Africa.

ALSFRS-R showed feasibility and reliability in detecting disease progression remotely.